Vanda Pharmaceuticals Inc.
For the period ended Dec 30, 2025. Filed Dec 31, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Dec 30, 2025 · Filed Dec 31, 2025
Use the contents to explore the available documents and sections.
VNDA$3.82+6.4%Stored close · as of Nov 6, 2026
Contents
(Exact name of Registrant as specified in its charter)
| Delaware | 001-34186 | 03-0491827 |
|---|---|---|
| (State or other jurisdiction of incorporation) | (Commission File No.) | (IRS Employer Identification No.) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.